Experts discuss how checkpoint inhibitors, cystectomy, and other treatment modalities fit into the current landscape for non–muscle-invasive bladder cancer.
Suzanne B. Merrill, MD, FACS
Advertisement
Articles by Suzanne B. Merrill, MD, FACS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Blood-Based Lung Cancer Screening Tool Earns FDA Breakthrough Device Status
2
One of “The Best Opportunities” for Long-Term Remission in Multiple Myeloma
3
What Does Priority Review Mean for Subcutaneous Amivantamab in HNSCC?
4
FDA Type C Meeting Granted for Pulmonary Metastatic Osteosarcoma Therapy
5